These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20185345)

  • 1. Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype.
    Landburg PP; Teerlink T; Biemond BJ; Brandjes DP; Muskiet FA; Duits AJ; Schnog JB;
    Blood Cells Mol Dis; 2010 Apr; 44(4):229-32. PubMed ID: 20185345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.
    Antwi-Boasiako C; Campbell AD
    Vasc Health Risk Manag; 2018; 14():199-204. PubMed ID: 30233199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease.
    Schnog JB; Teerlink T; van der Dijs FP; Duits AJ; Muskiet FA;
    Ann Hematol; 2005 May; 84(5):282-6. PubMed ID: 15599544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension.
    van Beers EJ; van Eck-Smit BL; Mac Gillavry MR; van Tuijn CF; van Esser JW; Brandjes DP; Kappers-Klunne MC; Duits AJ; Biemond BJ; Schnog JJ;
    Chest; 2008 Mar; 133(3):646-52. PubMed ID: 18198257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.
    Kato GJ; Wang Z; Machado RF; Blackwelder WC; Taylor JG; Hazen SL
    Br J Haematol; 2009 May; 145(4):506-13. PubMed ID: 19344390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis.
    Landburg PP; Teerlink T; Muskiet FA; Duits AJ; Schnog JJ;
    Am J Hematol; 2008 Jul; 83(7):577-9. PubMed ID: 18383318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study.
    van Tuijn CFJ; Schimmel M; van Beers EJ; Nur E; Biemond BJ
    Am J Hematol; 2017 Oct; 92(10):E584-E590. PubMed ID: 28699283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
    Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
    Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.
    El-Shanshory M; Badraia I; Donia A; Abd El-Hameed F; Mabrouk M
    Eur J Haematol; 2013 Jul; 91(1):55-61. PubMed ID: 23551575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension and nitric oxide depletion in sickle cell disease.
    Bunn HF; Nathan DG; Dover GJ; Hebbel RP; Platt OS; Rosse WF; Ware RE
    Blood; 2010 Aug; 116(5):687-92. PubMed ID: 20395414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1?
    Martins SR; Toledo SLO; da Silva AJ; Mendes FS; de Oliveira MM; Ferreira LGR; Dusse LMS; Carvalho MDG; Rios DRA; Alpoim PN; Pinheiro MB
    Ann Hematol; 2022 Feb; 101(2):273-280. PubMed ID: 34665295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine levels in children with β-thalassemia and their correlations to tricuspid regurgitant jet velocity.
    Mohamed el-S; Ibrahim B; Amr D; Noha el-K; Mokhtar M
    Pediatr Blood Cancer; 2014 Sep; 61(9):1540-3. PubMed ID: 24753210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocytosis is associated with hemolysis in sickle cell disease.
    Wongtong N; Jones S; Deng Y; Cai J; Ataga KI
    Hematology; 2015 Dec; 20(10):593-7. PubMed ID: 25875078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension.
    Landburg PP; Teerlink T; van Beers EJ; Muskiet FA; Kappers-Klunne MC; van Esser JW; Mac Gillavry MR; Biemond BJ; Brandjes DP; Duits AJ; Schnog JJ;
    Haematologica; 2008 Sep; 93(9):1410-2. PubMed ID: 18641026
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates.
    Yates AM; Joshi VM; Aygun B; Moen J; Smeltzer MP; Govindaswamy D; Dowdy J; Cotton A; Kang G; Ware RE; Hankins JS
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27717. PubMed ID: 30907497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients.
    Nur E; Brandjes DP; Schnog JJ; Otten HM; Fijnvandraat K; Schalkwijk CG; Biemond BJ;
    Br J Haematol; 2010 Oct; 151(1):62-9. PubMed ID: 20678158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.
    Kato GJ; Gladwin MT; Steinberg MH
    Blood Rev; 2007 Jan; 21(1):37-47. PubMed ID: 17084951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An adolescent with sickle cell anaemia experiencing disease-related complications: priapism and leg ulcer--a management challenge.
    Vasconcelos A; Prior AR; Ferrão A; Morais A
    BMJ Case Rep; 2012 Apr; 2012():. PubMed ID: 22605005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priapism in sickle-cell disease: a hematologist's perspective.
    Kato GJ
    J Sex Med; 2012 Jan; 9(1):70-8. PubMed ID: 21554552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
    Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
    Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.